share_log

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Benzinga Real-time News ·  Aug 4, 2022 09:28

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment